Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Oncotarget|December 10, 2016
Clinical relevance of cell-free DNA in gastrointestinal tract malignancyYuan-Tzu Lan, Ming-Huang Chen, Wen-Liang Fang, et al.
American Journal of Surgery|February 15, 2014
Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancerChih-Sheng Huang, Jen-Kou Lin, Ling-Wei Wang, et al.
The International Journal of Biological Markers|March 12, 2019
Clinicopathological and molecular differences in colorectal cancer according to locationYu-Lun Hsu, Chun-Chi Lin, Jeng-Kai Jiang, et al.
BMC Cancer|April 22, 2015
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomyKuen-Feng Chen, Chueh-Chuan Yen, Jen-Kou Lin, et al.
Hepato-Gastroenterology|July 10, 2015
The Number of Risk Factors Determines the Outcome Of Stage II Colorectal Cancer PatientsHung-Hsin Lin, Hsueh-Li Yang, Jen-Kou Lin, et al.
Cancers|April 30, 2021
Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal CancerYuan-Tzu Lan, Shih-Ching Chang, Pei-Ching Lin, et al.
World Journal of Surgical Oncology|July 7, 2018
Differences in gene mutations according to gender among patients with colorectal cancerYi-Jian Tsai, Sheng-Chieh Huang, Hung-Hsin Lin, et al.
Oncotarget|January 19, 2017
Building personalized treatment plans for early-stage colorectal cancer patientsHung-Hsin Lin, Nien-Chih Wei, Teh-Ying Chou, et al.
International Journal of Colorectal Disease|July 19, 2022
Clinical outcome of local treatment and radical resection for pT1 rectal cancerSummer Sheue-Tsuey Pai, Hung-Hsin Lin, Hou-Hsuan Cheng, et al.
International Journal of Colorectal Disease|May 23, 2013
Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasisYen-Chen Shao, Yu-Yao Chang, Jen-Kou Lin, et al.
Pageof 19